OR WAIT null SECS
May 28, 2020
CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna’s vaccine against SARS-CoV-2.
April 02, 2020
Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.
The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
March 05, 2020
FDA issued a notice to drug compounders regarding the transition of licensure of biologics to the Public Health Service Act.
March 02, 2020
The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.
February 06, 2020
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
February 02, 2020
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.
February 01, 2020
CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.
January 09, 2020
Phillips-Medisize has announced that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.